1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Mathematical modelling of post-filter ionized calcium during citrate anticoagulated continuous renal replacement therapy
(
- Contribution to journal › Article
- 2015
-
Mark
Blood treatment apparatus adapted to preserve parts thereof
2015)(
- Patent › Patent
-
Mark
Simplified citrate anticoagulation for CRRT without calcium replacement.
(
- Contribution to journal › Article
- 2012
-
Mark
Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions.
(
- Contribution to journal › Article
- 2010
-
Mark
Infusion fluids contain harmful glucose degradation products.
(
- Contribution to journal › Article
- 2009
-
Mark
3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids infused into the peritoneal cavity cannot be found in plasma.
2009) 12th Congress of the International-Society-for-Peritoneal-Dialysis In Peritoneal Dialysis International 29 Suppl 2. p.28-31(
- Contribution to journal › Article
-
Mark
The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status
(
- Contribution to journal › Article
- 2008
-
Mark
3,4-dge in peritoneal dialysis fluids cannot be found in plasma after infusion into the peritoneal cavity.
(
- Contribution to journal › Article
- 2006
-
Mark
Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture.
(
- Contribution to journal › Article
-
Mark
How to avoid glucose degradation products in peritoneal dialysis fluids
(
- Contribution to journal › Article